Biospecimen Bank
Biospecimen Bank
批准号:
10242156
负责人:
Wing C. Chan
金额:
$16.63万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-02 至 2023-08-31
关键词:
9p24Animal ModelAreaBiodistributionBiological AssayBiological Specimen BanksBiological Specimen databaseBiometryBiostatistics CoreBloodBlood Component RemovalBlood specimenBone MarrowCancer CenterCell SeparationCellsChromosomesCitiesCity of Hope Comprehensive Cancer CenterClassificationClinicalCollaborationsCollectionCommunitiesComplementComplexComprehensive Cancer CenterCore FacilityCytogeneticsCytometryDNA Sequencing FacilityDataData SetDatabasesDerivation procedureDevelopmentDiagnosisDrug KineticsEnrollmentEnsureFundingGene Expression ProfilingGenomicsGoalsHistologicHodgkin DiseaseHumanIL2RA geneImmuneImmunofluorescence ImmunologicImmunophenotypingIndividualInformaticsInfrastructureInstitutionLeukapheresisLinkLymphomaMalignant lymphoid neoplasmModelingMolecularMonitorMulticenter StudiesNon-Hodgkin&aposs LymphomaParaffinPathologicPathologyPatientsPerformancePhenotypePopulationPreparationProcessProgram Research Project GrantsQuality ControlRegistriesResearchResearch PersonnelResearch Project GrantsResearch SupportResourcesSamplingServicesShipsSpecimenStainsTimeTissue MicroarrayTissuesTumor TissueWorkbasiliximabbiomarker evaluationcareerchimeric antigen receptor T cellsdata repositorydesigndisease classificationimprovedinformatics infrastructureleukemia/lymphomamemberpatient derived xenograft modelprogramsprospectivequality assurancespatial relationshiptumortumor microenvironment
中文摘要
Core C旨在满足项目的特定需求,同时利用
现有的癌症中心(CC)的核心,没有不必要的重复服务。该核心将密切合作,
与许多CC核心以及其他SPORE核心协同,为所有
建议的项目和可能的SPORE间合作。
这个核心的首要目标是提供高质量,注释良好和严格的质量控制
项目的生物标本,开发和实施生物标本分析所需的测定
并与核心B合作,建立信息学基础设施,以促进研究的各个方面
到生物标本。
具体目标1是在以下领域提供服务:(1)新鲜和石蜡的收购和银行业务-
淋巴瘤的固定组织以及前瞻性获得的血液和骨髓(BM)样本,
回顾性地从COH淋巴瘤SPORE招募的患者中;我们将确保快速收集和
处理、适当的储存和监测,以及适当的注释和记录保存;(2)全面
淋巴瘤标本的检查,以确保正确的诊断和分类,包括
免疫组化、流式细胞术、分子病理学和细胞遗传学研究;(3)性能和
协助淋巴瘤组织和细胞的常规组织学和免疫组化染色,以及
专门的组织学服务,如制备多肿瘤块或组织微阵列,
研究人员的规格。将根据需要提供额外的专门服务。
收集白细胞分离标本以生成CAR-T细胞的项目(项目1);
通过多光谱多重免疫荧光检测复杂型霍奇金淋巴瘤和宿主细胞群
(mIF)表型和基因表达谱(GEP)(项目3);细胞遗传学和基因组表征
和制备样品以产生原发性患者来源的异种移植物(PDX)非肿瘤细胞。
霍奇金淋巴瘤模型(项目4)。
由于与核心C功能相关的数据集的复杂性,在具体目标2中,我们将
与核心B(研究信息学)合作,设计、构建和集成与以下内容相关的数据库:
生物标本,以改善其功能和连接,以支持孢子项目和合作,
NCI赞助的其他项目。
英文摘要
Core C is designed to meet the specific needs of the projects and at the same time draw on the strength of the
existing Cancer Center (CC) cores without unnecessary duplication of services. This Core will work closely and
synergistically with a number of CC Cores as well as other SPORE Cores to provide exceptional support for all
the proposed projects and possible inter-SPORE collaborations.
The overarching goals of this core is to provide high quality, well annotated and strictly quality controlled
biospecimens for the projects, to develop and implement assays needed for the analysis of the biospecimens
and to collaborate with Core B to build the informatics infrastructures to facilitate all aspects of research linked
to biospecimens.
Specific Aim 1 is to provides services in the following areas: (1) acquisition and banking of fresh and paraffin-
fixed tissues of lymphoma and blood and bone marrow (BM) samples obtained prospectively and
retrospectively from patients enrolled on the COH lymphoma SPORE; we will ensure rapid collection and
processing, proper storage and monitoring, and proper annotation and record keeping; (2) comprehensive
work-up of lymphoma specimens to ensure correct diagnosis and classification, including
immunohistochemical, flow cytometric, molecular pathologic, and cytogenetic studies; (3) performance and
assistance in routine histologic and immunohistochemical staining of lymphoma tissues and cells, as well as
specialized histologic services such as preparation of multi-tumor blocks or tissue microarrays to the
specifications of researchers. Additional specialized services will be performed according to the needs of the
projects with the collection of leukapheresis specimens to generate CAR-T cells (Project 1); characterization of
complex Hodgkin lymphoma and host cell populations through multispectral multiplexed immunofluorescence
(mIF) phenotyping and gene expression profiling (GEP) (Project 3); cytogenetic and genomic characterization
of lymphomas and the preparation of samples to generate primary patient-derived xenograft (PDX) non-
Hodgkin lymphoma models (Project 4).
Because of the complexity of the datasets associated with the functions of Core C, in Specific Aim 2, we will
collaborate with Core B (Research Informatics) to design, build, and integrate databases relevant to
biospecimens to improve their functionality and connectivity to support SPORE projects and collaborations on
other NCI-sponsored projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pre-analytical variables of bioanalytes affecting the accuracy of PTCL diagnostic and prognostic genetic signatures
-
批准号:10300391
-
项目类别:
-
资助金额:$39.11万
-
财政年份:2021
-
负责人:Wing C. Chan
-
依托单位:
Pre-analytical variables of bioanalytes affecting the accuracy of PTCL diagnostic and prognostic genetic signatures
-
批准号:10491082
-
项目类别:
-
资助金额:$36.0万
-
财政年份:2021
-
负责人:Wing C. Chan
-
依托单位:
Cooperative role of TET2 and IDH2 mutations in angioimmunoblastic T-cell lymphomagenesis
-
批准号:10672370
-
项目类别:
-
资助金额:$47.86万
-
财政年份:2021
-
负责人:Wing C. Chan
-
依托单位:
Pre-analytical variables of bioanalytes affecting the accuracy of PTCL diagnostic and prognostic genetic signatures
-
批准号:10684317
-
项目类别:
-
资助金额:$35.99万
-
财政年份:2021
-
负责人:Wing C. Chan
-
依托单位:
Cooperative role of TET2 and IDH2 mutations in angioimmunoblastic T-cell lymphomagenesis
-
批准号:10299140
-
项目类别:
-
资助金额:$50.08万
-
财政年份:2021
-
负责人:Wing C. Chan
-
依托单位:
Cooperative role of TET2 and IDH2 mutations in angioimmunoblastic T-cell lymphomagenesis
-
批准号:10453656
-
项目类别:
-
资助金额:$47.86万
-
财政年份:2021
-
负责人:Wing C. Chan
-
依托单位:
Development of a Novel Clinical Diagnostic Assay for Peripheral T-cell Lymphoma (PTCL)
-
批准号:9555564
-
项目类别:
-
资助金额:$29.94万
-
财政年份:2018
-
负责人:Wing C. Chan
-
依托单位:
Molecular diagnostic and prognostic signatures for PTCL
-
批准号:10017897
-
项目类别:
-
资助金额:$30.1万
-
财政年份:2017
-
负责人:Wing C. Chan
-
依托单位:
Molecular diagnostic and prognostic signatures for PTCL
-
批准号:10226182
-
项目类别:
-
资助金额:$24.65万
-
财政年份:2017
-
负责人:Wing C. Chan
-
依托单位:
Molecular Signatures to Improve Diagnosis and Outcome Pr
-
批准号:7913564
-
项目类别:
-
资助金额:$36.93万
-
财政年份:2009
-
负责人:Wing C. Chan
-
依托单位:
Gene expression profiling and pathway targeted therapy in peripheral T-cell
-
批准号:7715220
-
项目类别:
-
资助金额:$10.3万
-
财政年份:2009
-
负责人:Wing C. Chan
-
依托单位:
Molecular Signatures to Improve Diagnosis and Outcome Pr
-
批准号:6931273
-
项目类别:
-
资助金额:$171.49万
-
财政年份:2005
-
负责人:Wing C. Chan
-
依托单位:
Molecular Signatures to Improve Diagnosis and Outcome Pr
-
批准号:7125961
-
项目类别:
-
资助金额:$166.41万
-
财政年份:2005
-
负责人:Wing C. Chan
-
依托单位:
Molecular Signatures to Improve Diagnosis and Outcome Pr
-
批准号:7240538
-
项目类别:
-
资助金额:$142.44万
-
财政年份:2005
-
负责人:Wing C. Chan
-
依托单位:
Molecular Signatures to Improve Diagnosis and Outcome Pr
-
批准号:7283929
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2005
-
负责人:Wing C. Chan
-
依托单位:
Molecular Signatures to Improve Diagnosis and Outcome Pr
-
批准号:7630591
-
项目类别:
-
资助金额:$172.08万
-
财政年份:2005
-
负责人:Wing C. Chan
-
依托单位:
Molecular Signatures to Improve Diagnosis and Outcome Pr
-
批准号:7478506
-
项目类别:
-
资助金额:$167.4万
-
财政年份:2005
-
负责人:Wing C. Chan
-
依托单位:
Biospecimen Bank
-
批准号:10456958
-
项目类别:
-
资助金额:$17.65万
-
财政年份:2004
-
负责人:Wing C. Chan
-
依托单位:
MOLECULAR CLASSIFICATION OF B-CELL LYMPHOMA
-
批准号:6074235
-
项目类别:
-
资助金额:$37.91万
-
财政年份:1999
-
负责人:Wing C. Chan
-
依托单位:
MOLECULAR CLASSIFICATION OF B-CELL LYMPHOMA
-
批准号:6175326
-
项目类别:
-
资助金额:$104.79万
-
财政年份:1999
-
负责人:Wing C. Chan
-
依托单位:
海外基金